HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

The National Institute of Allergy and Infectious Diseases (NIAID) today released the NIAID Counter-Bioterrorism Research Agenda for CDC Category A Agents, a document describing the Institute's accelerated research plan for the most threatening agents of bioterrorism. The agenda outlines the research NIAID will undertake to help protect civilian populations from diseases such as smallpox, anthrax and plague should they be unleashed intentionally by those who wish to do harm.

The comprehensive plan includes short-, intermediate- and long-term research goals and describes specifically how bioterrorism countermeasures will be developed for each microbe. The document also contains a copy of the Strategic Plan for Counter-Bioterrorism Research of the NIAID, which provides a general overview of the Institute's broad plans for attacking the full range of potential bioterrorism pathogens.

"Research is a vital element of bioterrorism defense," says HHS Secretary Tommy G. Thompson. "The NIAID Counter-Bioterrorism Research Agenda describes the highest priorities of an accelerated program to expand research on bioterrorism agents and to quickly develop new diagnostics, drugs and vaccines to protect the public."

The Research Agenda was developed by NIAID scientists and reviewed by an outside panel of experts from academia, industry and government in early February. The plan focuses on the Category A diseases as described by the Centers for Disease Control and Prevention (CDC): anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers and botulism. Those diseases cause high death rates or serious illness, are relatively easy to spread, could cause public panic or require special steps for public health preparedness. NIAID plans to develop research plans for CDC Category B and C agents in the near future.

As the National Institutes of Health's lead institute on immunology and infectious diseases research, NIAID has made many key contribu
'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% and reduces ... Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict best advertising ...
(Date:11/11/2019)... ... November 11, 2019 , ... MicroGenDX, the world leader ... role in the award-winning study “Next Generation Sequencing for the Diagnosis of Periprosthetic ... laboratory processed samples using Next Generation DNA Sequencing to examine the ability of ...
(Date:11/7/2019)... ... 2019 , ... R3 Stem Cell is now offering its comprehensive Online ... code to use during checkout is FIFTYOFF and applies to both the one month ... regenerative therapies with over 12,000 successful stem cell procedures performed nationwide. A couple years ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... FALLS, Wis. (PRWEB) , ... November 12, 2019 ... ... label food ingredient solutions for the food and beverage industry launched a new ... to improve the digital experience. Now, the website offers global visitors updated ingredient ...
(Date:11/6/2019)... ... November 06, 2019 , ... LeadingBiotech ,?an exclusive event ... its East/West CEO conference to be held January 11-12, 2020 at ... off the week of the J.P. Morgan Healthcare Conference and other biotech industry ...
(Date:11/2/2019)... ... 31, 2019 , ... Join Patrick Raber, PhD, Manager, Research ... on Friday, November 15, 2019 at 1pm EST to learn about immunoSEQ ... T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely utilized to understand ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, ... sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, ... California. , The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge ...
Breaking Biology Technology:
Cached News: